Advertisement
EVEX vs RCAT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVEX is a Hold and RCAT is a Hold.
EVEX's RSI Oscillator ascending out of oversold territory
The RSI Indicator for EVEX moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 34 of the 36 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for EVEX just turned positive on October 19, 2026. Looking at past instances where EVEX's MACD turned positive, the stock continued to rise in 34 of 44 cases over the following month. The odds of a continued upward trend are 77%.
Following a +2.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where EVEX advanced for three days, in 181 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
EVEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EVEX as a result. In 77 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for EVEX entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: EVEX's P/B Ratio (23.354) is very high in comparison to the industry average of (5.157). P/E Ratio (-2.468) is within average values for comparable stocks, (18.245). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. EVEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
RCAT in +3.70% Uptrend, rising for three consecutive days on October 29, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RCAT advanced for three days, in 233 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCAT's RSI Indicator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for RCAT just turned positive on October 27, 2026. Looking at past instances where RCAT's MACD turned positive, the stock continued to rise in 35 of 40 cases over the following month. The odds of a continued upward trend are 88%.
RCAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 47 cases where RCAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCAT as a result. In 71 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for RCAT entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.296) is normal, around the industry mean (5.157). P/E Ratio (-5.000) is within average values for comparable stocks, (18.245). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (11.820) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. RCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
EVEX | RCAT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 91 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 86 | 89 | |
P/E GROWTH RATING 1..100 | 14 | 12 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RCAT's Valuation (35) in the null industry is somewhat better than the same rating for EVEX (70). This means that RCAT’s stock grew somewhat faster than EVEX’s over the last 12 months.
RCAT's Profit vs Risk Rating (91) in the null industry is in the same range as EVEX (100). This means that RCAT’s stock grew similarly to EVEX’s over the last 12 months.
RCAT's SMR Rating (97) in the null industry is in the same range as EVEX (100). This means that RCAT’s stock grew similarly to EVEX’s over the last 12 months.
EVEX's Price Growth Rating (86) in the null industry is in the same range as RCAT (89). This means that EVEX’s stock grew similarly to RCAT’s over the last 12 months.
RCAT's P/E Growth Rating (12) in the null industry is in the same range as EVEX (14). This means that RCAT’s stock grew similarly to EVEX’s over the last 12 months.
| EVEX | RCAT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 87% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 87% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 83% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 79% |
| Advances ODDS (%) | 2 days ago 80% | 7 days ago 90% |
| Declines ODDS (%) | 6 days ago 83% | 3 days ago 81% |
| BollingerBands ODDS (%) | 3 days ago 66% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 82% | 2 days ago 77% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EVEX’s FA Score shows that 1 FA rating(s) are green while RCAT’s FA Score has 1 green FA rating(s).
- EVEX’s FA Score: 1 green, 4 red.
- RCAT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EVEX’s TA Score shows that 5 TA indicator(s) are bullish while RCAT’s TA Score has 4 bullish TA indicator(s).
- EVEX’s TA Score: 5 bullish, 3 bearish.
- RCAT’s TA Score: 4 bullish, 4 bearish.
Price Growth
EVEX (@Aerospace & Defense) experienced а -8.38% price change this week, while RCAT (@Aerospace & Defense) price change was -8.42% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.90%. For the same industry, the average monthly price growth was -10.55%, and the average quarterly price growth was -19.22%.
Reported Earning Dates
EVEX is expected to report earnings on Mar 17, 2027.
RCAT is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Aerospace & Defense (-3.90% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
Advertisement
EVEX and
Correlation & Price change
A.I.dvisor indicates that over the last year, EVEX has been closely correlated with ACHR. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if EVEX jumps, then ACHR could also see price increases.
| Ticker / NAME | Correlation To EVEX | 1D Price Change % | ||
|---|---|---|---|---|
| EVEX | 100% | +2.00% | ||
| ACHR - EVEX | 71% Closely correlated | -0.96% | ||
| RCAT - EVEX | 52% Loosely correlated | +0.22% | ||
| EVTL - EVEX | 50% Loosely correlated | -4.05% | ||
| EH - EVEX | 48% Loosely correlated | +1.60% | ||
| RDW - EVEX | 48% Loosely correlated | +3.70% | ||
More | ||||
RCAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, RCAT has been loosely correlated with KTOS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RCAT jumps, then KTOS could also see price increases.
| Ticker / NAME | Correlation To RCAT | 1D Price Change % | ||
|---|---|---|---|---|
| RCAT | 100% | +0.22% | ||
| KTOS - RCAT | 65% Loosely correlated | +1.89% | ||
| DPRO - RCAT | 64% Loosely correlated | -3.78% | ||
| LUNR - RCAT | 63% Loosely correlated | +6.29% | ||
| KOPN - RCAT | 60% Loosely correlated | +4.65% | ||
| AIRO - RCAT | 58% Loosely correlated | +6.37% | ||
More | ||||